Harshan treated with one-half the dosage of doxycycline used in the current study.
197
However, serological response rate seemed to be much lower in recently published 198 studies treated with the same dosage of doxycycline used in the current study (19-21).
199
The response rate was 63.4% and 82.9% in early syphilis in Tsai and Li's study and re-infection might be lower. Furthermore, our study mainly analysised the 212 patients completed 12 months follow up, patients lost to follow up were excluded.
213
Considering all the 163 intention-to-treat patients, the success rate would be much 
224
This study has several limitations. Firstly, Benzathine penicillin was not 225 available in our hospital during the study period, the absence of a control group 226 treated with benzathine penicillin G is a major concern. Secondly, the clinical data 227 were collected from a single center and the study was retrospective, there were no 
